SciELO - Scientific Electronic Library Online

 
vol.149 número6Tumores Neuroendocrinos: un desafío transversalReflexión sobre la equidad del sistema de calificación médica para invalidez en Chile índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

VLEIVA-VASQUEZ, Ofelia  y  PEREZ-CRUZ, Pedro. Paracetamol as an adjuvant to opioids for cancer pain management. Rev. méd. Chile [online]. 2021, vol.149, n.6, pp.899-905. ISSN 0034-9887.  http://dx.doi.org/10.4067/s0034-98872021000600899.

Cancer related pain is one of the most frequent and relevant symptoms in patients with malignant tumors, causing a huge impact in their quality of life. According to the Chilean Public Health System Technical Report of the Cancer Pain Control and Palliative Care Program 2013-2014, 90% of cancer patients admitted to the Program experienced pain, being moderate or intense in 34%. International and local standards recommend the use of strong opioids (morphine, methadone, or fentanyl) associated with adjuvants such as paracetamol as an initial strategy for pain management. This recommendation assumes that the use of combined analgesics could allow the use of lower opioid doses to obtain similar analgesic effect, decreasing the occurrence of opioid side effects. However, this technical report also describes that there is uncertainty about the impact of paracetamol as an adjuvant in patients with cancer pain who are already receiving strong opioids. This review aims to describe the current state of the art regarding the role of paracetamol as a coadjuvant in cancer pain patients.

Palabras clave : Acetaminophen; Analgesics, Opioid; Cancer Pain.

        · texto en Español     · Español ( pdf )